The Long Run with Luke Timmerman

Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

Mar 6, 2024
Guest
Valerie Daggett
Valerie Daggett, Founder and CEO of AltPep, discusses early detection of Alzheimer's through blood tests and therapeutic interventions. She shares her academic journey in protein studies, relocation for collaboration, and innovative approaches in detecting and treating Alzheimer's. The podcast highlights the importance of targeting toxic oligomers in pathology and the potential of blood-based diagnostics for amyloid diseases.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Exploring the Speaker's Academic Journey in Protein Studies
02:34 • 9min
3
Relocating for Collaboration and Collegial Environment
11:17 • 3min
4
Exploring Computational Protein Studies and Therapeutic Design for Alzheimer's Disease
14:27 • 18min
5
Exploring Toxic Oligomers in Alzheimer's Disease Pathology
31:59 • 3min
6
Innovative Approaches to Detect and Treat Alzheimer's
34:37 • 23min
7
Innovative Approach to Disease Treatments
57:09 • 5min